Status:
COMPLETED
Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery
Lead Sponsor:
Yonsei University
Conditions:
Non-thyroidal Illness Syndrome
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This study is planned to medicate oral T3(Liothyronine)to the patients who are planned to have OPCAB(off- pump coronary bypass graft surgery. The aim of this study was to assess the effects of oral tr...
Eligibility Criteria
Inclusion
- Patients who are undergoing Off-pump coronary artery bypass graft
Exclusion
- No normal sinus rhythm,
- History of thyroid disease
- Abnormal thyroid hormone
- Renal dysfunction
- Hepatic dysfunction
- LVEF \<30%
- Recent MI
- Active infection 1\~15
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01153360
Start Date
June 1 2010
End Date
September 1 2011
Last Update
July 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea